Alzheimer Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
Clínica Oftalmológica Dr. Castilla, Barcelona, Spain.
Sci Rep. 2018 Nov 5;8(1):16345. doi: 10.1038/s41598-018-34577-3.
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker for Alzheimer's Disease based on previously reported thinning of the retinal nerve fiber layer (RNFL) in Alzheimer's disease's (AD) and Mild Cognitive Impairment (MCI). However, other studies have not shown such results. 930 individuals (414 cognitively healthy individuals, 192 probable amnestic MCI and 324 probable AD) attending a memory clinic were consecutively included and underwent spectral domain OCT (Maestro, Topcon) examinations to assess differences in peripapillary RNFL thickness, using a design of high ecological validity. Adjustment by age, education, sex and OCT image quality was performed. We found a non-significant decrease in mean RNFL thickness as follows: control group: 100,20 ± 14,60 µm, MCI group: 98,54 ± 14,43 µm and AD group: 96,61 ± 15,27 µm. The multivariate adjusted analysis revealed no significant differences in mean overall (p = 0.352), temporal (p = 0,119), nasal (p = 0,151), superior (p = 0,435) or inferior (p = 0,825) quadrants between AD, MCI and control groups. These results do not support the usefulness of peripapillary RNFL analysis as a marker of cognitive impairment or in discriminating between cognitive groups. The analysis of other OCT measurements in other retinal areas and layers as biomarkers for AD should be tested further.
光学相干断层扫描(OCT)的应用已被提议作为阿尔茨海默病(AD)的潜在生物标志物,基于先前报道的 AD 和轻度认知障碍(MCI)中视网膜神经纤维层(RNFL)变薄。然而,其他研究并未显示出这样的结果。930 名(414 名认知健康个体、192 名可能的遗忘型 MCI 和 324 名可能的 AD)参加记忆诊所的个体被连续纳入并接受了光谱域 OCT(Maestro,Topcon)检查,以评估使用高生态有效性设计的视盘周围 RNFL 厚度的差异。通过年龄、教育、性别和 OCT 图像质量进行调整。我们发现平均 RNFL 厚度没有明显下降,结果如下:对照组:100.20±14.60μm,MCI 组:98.54±14.43μm,AD 组:96.61±15.27μm。多变量调整分析显示,总体(p=0.352)、颞部(p=0.119)、鼻侧(p=0.151)、上侧(p=0.435)和下侧(p=0.825)象限的平均无显著差异。这些结果不支持视盘周围 RNFL 分析作为认知障碍的标志物或区分认知障碍组的有用性。应进一步测试其他 OCT 测量在其他视网膜区域和层中的分析作为 AD 的生物标志物。